Oppenheimer & Co. Inc. Makes New Investment in First Trust Nasdaq Pharmaceuticals ETF $FTXH

Oppenheimer & Co. Inc. acquired a new position in shares of First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 145,018 shares of the company’s stock, valued at approximately $6,014,000.

Other hedge funds have also bought and sold shares of the company. Flagship Harbor Advisors LLC lifted its stake in shares of First Trust Nasdaq Pharmaceuticals ETF by 50.9% in the 3rd quarter. Flagship Harbor Advisors LLC now owns 8,500 shares of the company’s stock valued at $352,000 after purchasing an additional 2,868 shares during the period. Englebert Financial Advisers LLC bought a new position in shares of First Trust Nasdaq Pharmaceuticals ETF during the 3rd quarter worth approximately $751,000. Cyndeo Wealth Partners LLC bought a new position in shares of First Trust Nasdaq Pharmaceuticals ETF during the 3rd quarter worth approximately $1,524,000. Trust Co. of Oklahoma acquired a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the 3rd quarter worth approximately $1,283,000. Finally, MinichMacGregor Wealth Management LLC acquired a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the 3rd quarter worth approximately $968,000.

First Trust Nasdaq Pharmaceuticals ETF Stock Up 0.3%

NASDAQ:FTXH opened at $43.25 on Thursday. The company has a fifty day moving average of $41.60 and a 200-day moving average of $37.09. The firm has a market capitalization of $1.15 billion, a P/E ratio of 14.51 and a beta of 0.45. First Trust Nasdaq Pharmaceuticals ETF has a twelve month low of $29.40 and a twelve month high of $43.52.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Thursday, September 24th were paid a dividend of $0.0113 per share. This is a drop from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.0920. This represents a $0.05 annualized dividend and a yield of 0.1%. The ex-dividend date of this dividend was Thursday, September 24th.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.